Friday, May 29, 2020
Thursday, May 28, 2020
Wednesday, May 27, 2020
Monday, May 25, 2020
Saturday, May 23, 2020
Thursday, May 21, 2020
Tuesday, May 19, 2020
Monday, May 18, 2020
X-37B: NASA Experiments Prepare for Mars Journey
On its current mission,launched on 17 May 2017 aboard a United Launch Alliance Atlas V rocket, the US Space Force X-37B,a small, highly classified space plane,will deploy the US Air Force Academy's FalconSAT-8 satellite,used for technology demos and to train cadets in space operations.FalconSAT-8 also contains two NASA experiments related to the Journey to Mars.The studies will examine the effects of the harsh outer space environment, especially cosmic radiation,on materials samples and seeds.The Materials Exposure and Technology Innovation in Space (METIS) will expose a plate of quarter-sized materials samples to help spacecraft designers choose optimal materials for specific aerospace applications, such as thermal protection for antennas and other space hardware.Data from the samples testing will increase the lifespan and improve the operations of future spacecraft and systems needed for the Journey to Mars, NASA said.METIS took over from a previous ISS experiment, the Materials on ISS Experiment (MISSE),in 2015 aboard the X-37B.*
The new seeds experiment will evaluate the effects of ambient space radiation on seeds for food plants.This is crucial for deep space explorers who may need to grow some of their own food.The X-37B reportedly facilitates exposure to different radiation types than are possible on the ISS,which is locked in a particular orbit.*
The new seeds experiment will evaluate the effects of ambient space radiation on seeds for food plants.This is crucial for deep space explorers who may need to grow some of their own food.The X-37B reportedly facilitates exposure to different radiation types than are possible on the ISS,which is locked in a particular orbit.*
Sunday, May 17, 2020
Friday, May 15, 2020
Thursday, May 14, 2020
Monday, May 11, 2020
Friday, May 8, 2020
Thursday, May 7, 2020
Monday, May 4, 2020
About Roche Group
The Roche Group is a Switzerland-based multinational pharma titan.In the US,it trades via the OTC pink sheets.Monday's performance was good, closing at 44.25,a gain of 1.41 (3.25%). The stock has a dividend yield of 2.65%.*
The company today received FDA emergency approval of its COVID-19 antibody test, which the firm says is nearby 100% accurate. According to CEO Severin Schwan of Austria:
From a technology point of view,it is much easier to ramp up antibody tests versus molecular tests.So I'm confident we will be able to provide this test in high quantities, and that this will allow the testing of broader parts of the population.Just to put this in perspective,in May alone, Roche will ramp up its production into the high double digit millions of tests per month.*
The FDA has only given twelve antibody test approvals despite hundreds of prospects.*
Roche Holding AG (RHHBY:OTCMKTS)
The company today received FDA emergency approval of its COVID-19 antibody test, which the firm says is nearby 100% accurate. According to CEO Severin Schwan of Austria:
From a technology point of view,it is much easier to ramp up antibody tests versus molecular tests.So I'm confident we will be able to provide this test in high quantities, and that this will allow the testing of broader parts of the population.Just to put this in perspective,in May alone, Roche will ramp up its production into the high double digit millions of tests per month.*
The FDA has only given twelve antibody test approvals despite hundreds of prospects.*
Roche Holding AG (RHHBY:OTCMKTS)
Saturday, May 2, 2020
Friday, May 1, 2020
Subscribe to:
Posts (Atom)